To enable more direct comparisons between the preclinical mouse model and the human tumors, we performed single-cell RNA sequencing of three human PN taken from biopsy specimens of two adult NF1 patients before and after the completion of their first cycle of MEK inhibitor (six total specimens; see Fig S1A). This evidence concerns the gene MAP2K7 and neurofibromatosis type 1.